Catalio Capital Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1958125 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$34,024,499

+$11,181,060 QoQ

Shares Held

269,309

+64.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

6.39%

of 13F equity value

Holder Rank

#262

of 2,266 holders

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Catalio Capital Management, LP holds $93,107,426 across 3 Drug Manufacturers - General names. GILD ranks #2 (36.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	138,946	$35,288,115
2	GILD	Gilead Sciences, Inc. This page	269,309	$34,024,499
3	BMY	Bristol Myers Squibb Co	412,961	$23,794,812

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,024,499	269,309	+64.3%	Shares	Sole	2026-08-14
2026-03-31	$22,843,439	163,905	-43.3%	Shares	Sole	2026-05-15
2025-12-31	$35,510,154	289,312	+27.5%	Shares	Sole	2026-02-17
2025-06-30	$25,153,631	226,875	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.